Refine
Has Fulltext
- yes (2)
Document Type
- Doctoral Thesis (2)
Language
- English (2)
Is part of the Bibliography
- yes (2)
Keywords
- Cre Rekombinase (1)
- Cre recombinase (1)
- Cyanobacteria (1)
- Cyanobakterien (1)
- DNA assembly (1)
- DNS Assemblierung (1)
- Genomic Mining (1)
- Natural Products (1)
- Naturstoffe (1)
- Nostoc punctiforme (1)
Institute
Since the golden era of antibiotics natural products are of ever growing interest to both basic research and applied sciences as they are the main source of new bioactive compounds delivering lead structures for new pharmaceuticals with potent antibiotic, anti-inflammatory or anti-cancer activities. Alongside the technological advances in high-throughput genome sequencing and the better understanding of the general organization of those modular biosynthetic assembly lines of secondary metabolites, there was also a shift from wet-lab screening of active cell extracts towards algorithm-based in silico screening for new natural product biosynthesis gene clusters (BGCs). Although the increasing availability of full genome sequences revealed that such non-ribosomal peptide synthetases (NRPS), polyketide synthases (PKS) and ribosomally synthesized and post-translationally modified peptides (RiPPs) can be found in all three kingdoms of life, certain phyla like actinobacteria and cyanobacteria show a very high density of these secondary metabolite BGCs.
The facultative symbiotic, N2-fixing model organism N. punctiforme PCC73102 is a terrestrial type IV cyanobacterium that not only dedicates are very large fraction of its genome to secondary metabolite production but is also amenable to genetic modification. AntiSMASH analysis of the genome showed that there are sixteen potential secondary metabolite BGCs encoded in N. punctiforme, but until now there were only two compounds assigned to their respective BGC leaving the remaining fourteen orphan. This makes the organism a perfect subject for the establishment of a novel combinatorial genomic mining approach for the detection of new natural products.
In the course of this study a combinatorial approach of genomic mining, independent monitoring techniques and alteration of cultivation conditions lead to new insights in cyanobacterial natural product biosynthesis and ultimately to the description of a novel compound produced by N. punctiforme. With the generation and investigation of a reporter strain library consisting of CFP-producing transcriptional reporter mutants for every predicted secondary metabolite BGC of N. punctiforme, it could be shown that natural product expression is in fact not silent for all those BGCs where no compound can be detected. Instead several distinct expression patterns could be described highlighting that secondary metabolite production is under tight regulation and only a minor fraction of these BGCs is in fact silent under standard laboratory conditions. Furthermore, increasing light intensity and carbon dioxide availability and cultivating N. punctiforme to very high cell densities had a tremendous impact on the overall metabolic activity of the organism. Investigation of high density cultivated cell extracts ultimately lead to the detection of a so far undescribed set of microviridins with unusual extended peptide sequences named Microviridin N3 – N9. Both cultivation of the transcriptional reporter mutants as well as RTqPCR-based detection of secondary metabolite BGC transcription levels revealed that in fact 50% of N. punctiforme’s natural product BGCs are upregulated under high cell density conditions. In contrast to this very broad response, co-cultivation of N. punctiforme in chemical or physical contact with a N-deprived host plant (Blasia pusilla) lead to a very specific upregulation of two natural product BGCs, namely RIPP3 and RIPP4. Although this response could be confirmed by various independent monitoring techniques and heavy analytical efforts were spent, no compound could be assigned to either of these BGCs.
This study is the first in-depth systematic investigation of a cyanobacterial secondary metabolome by a combinatorial approach of genome mining and independent monitoring techniques that can serve as a new strategic approach to gain further insight into natural product synthesis of various organisms. Although there are single well described examples of secondary metabolites like the cell differentiation factor PatS in Anabaena sp. strain PCC 7120, the level and extent of regulation observed in this study is unprecedented and understanding of these mechanisms might be the key to streamline natural product discovery. However, the results of this study also highlight that induction of secondary metabolite BGCs is not the real challenge. Instead the new insights point towards analytical issues being a severe hurdle and finding reliable strategies to overcome these problems might as well drive natural product discovery.
With Saccharomyces cerevisiae being a commonly used host organism for synthetic biology and biotechnology approaches, the work presented here aims at the development of novel tools to improve and facilitate pathway engineering and heterologous protein production in yeast. Initially, the multi-part assembly strategy AssemblX was established, which allows the fast, user-friendly and highly efficient construction of up to 25 units, e.g. genes, into a single DNA construct. To speed up complex assembly projects, starting from sub-gene fragments and resulting in mini-chromosome sized constructs, AssemblX follows a level-based approach: Level 0 stands for the assembly of genes from multiple sub-gene fragments; Level 1 for the combination of up to five Level 0 units into one Level 1 module; Level 2 for linkages of up to five Level 1 modules into one Level 2 module. This way, all Level 0 and subsequently all Level 1 assemblies can be carried out simultaneously. Individually planned, overlap-based Level 0 assemblies enable scar-free and sequence-independent assemblies of transcriptional units, without limitations in fragment number, size or content. Level 1 and Level 2 assemblies, which are carried out via predefined, computationally optimized homology regions, follow a standardized, highly efficient and PCR-free scheme. AssemblX follows a virtually sequence-independent scheme with no need for time-consuming domestication of assembly parts. To minimize the risk of human error and to facilitate the planning of assembly projects, especially for individually designed Level 0 constructs, the whole AssemblX process is accompanied by a user-friendly webtool. This webtool provides the user with an easy-to-use operating surface and returns a bench-protocol including all cloning steps. The efficiency of the assembly process is further boosted through the implementation of different features, e.g. ccdB counter selection and marker switching/reconstitution. Due to the design of homology regions and vector backbones the user can flexibly choose between various overlap-based cloning methods, enabling cost-efficient assemblies which can be carried out either in E. coli or yeast. Protein production in yeast is additionally supported by a characterized library of 40 constitutive promoters, fully integrated into the AssemblX toolbox. This provides the user with a starting point for protein balancing and pathway engineering. Furthermore, the final assembly cassette can be subcloned into any vector, giving the user the flexibility to transfer the individual construct into any host organism different from yeast.
As successful production of heterologous compounds generally requires a precise adjustment of protein levels or even manipulation of the host genome to e.g. inhibit unwanted feedback regulations, the optogenetic transcriptional regulation tool PhiReX was designed. In recent years, light induction was reported to enable easy, reversible, fast, non-toxic and nearly gratuitous regulation, thereby providing manifold advantages compared to conventional chemical inducers. The optogenetic interface established in this study is based on the photoreceptor PhyB and its interacting protein PIF3. Both proteins, derived from Arabidopsis thaliana, dimerize in a red/far-red light-responsive manner. This interaction depends on a chromophore, naturally not available in yeast. By fusing split proteins to both components of the optical dimerizer, active enzymes can be reconstituted in a light-dependent manner. For the construction of the red/far-red light sensing gene expression system PhiReX, a customizable synTALE-DNA binding domain was fused to PhyB, and a VP64 activation domain to PIF3. The synTALE-based transcription factor allows programmable targeting of any desired promoter region. The first, plasmid-based PhiReX version mediates chromophore- and light-dependent expression of the reporter gene, but required further optimization regarding its robustness, basal expression and maximum output. This was achieved by genome-integration of the optical regulator pair, by cloning the reporter cassette on a high-copy plasmid and by additional molecular modifications of the fusion proteins regarding their cellular localization. In combination, this results in a robust and efficient activation of cells over an incubation time of at least 48 h. Finally, to boost the potential of PhiReX for biotechnological applications, yeast was engineered to produce the chromophore. This overcomes the need to supply the expensive and photo-labile compound exogenously. The expression output mediated through PhiReX is comparable to the strong constitutive yeast TDH3 promoter and - in the experiments described here - clearly exceeds the commonly used galactose inducible GAL1 promoter.
The fast-developing field of synthetic biology enables the construction of complete synthetic genomes. The upcoming Synthetic Yeast Sc2.0 Project is currently underway to redesign and synthesize the S. cerevisiae genome. As a prerequisite for the so-called “SCRaMbLE” system, all Sc2.0 chromosomes incorporate symmetrical target sites for Cre recombinase (loxPsym sites), enabling rearrangement of the yeast genome after induction of Cre with the toxic hormonal substance beta-estradiol. To overcome the safety concern linked to the use of beta-estradiol, a red light-inducible Cre recombinase, dubbed L-SCRaMbLE, was established in this study. L-SCRaMbLE was demonstrated to allow a time- and chromophore-dependent recombination with reliable off-states when applied to a plasmid containing four genes of the beta-carotene pathway, each flanked with loxPsym sites. When directly compared to the original induction system, L-SCRaMbLE generates a larger variety of recombination events and lower basal activity. In conclusion, L-SCRaMbLE provides a promising and powerful tool for genome rearrangement.
The three tools developed in this study provide so far unmatched possibilities to tackle complex synthetic biology projects in yeast by addressing three different stages: fast and reliable biosynthetic pathway assembly; highly specific, orthogonal gene regulation; and tightly controlled synthetic evolution of loxPsym-containing DNA constructs.